Newswise -- Results of research from Hong Kong in this week's issue of The Lancet suggests that severe acute respiratory syndrome (SARS) without pneumonia could be common among populations affected by SARS outbreaks.
SARS has now affected 30 countries in five continents, with more than 8,400 cases and more than 910 deaths. A novel virus, the SARS coronavirus (SARS-CoV), is known to be the causative agent. Despite this knowledge, seroprevalence studies and mass screening for detection of possible subclinical and non-pneumonic infections are still lacking.
Patrick Woo from the University of Hong Kong and colleagues examined the seroprevalence of non-pneumonic SARS-CoV in the general population, non-pneumonic patients in hospital, and health-care workers during the SARS epidemic. Their findings suggest that non-pneumonic infections are more common than SARS-CoV pneumonia, providing a possible explanation for cases of SARS-CoV pneumonia in patients who had no obvious contact with other patients with SARS.
Source: The Lancet
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.